Author ORCID Identifier
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a novel pathogenic virus in late 2019, infecting millions of people with severe pulmonary infections. It spread worldwide in a short time and became a pandemic, after which the World Health Organization (WHO) declared it a public health emergency. Central nervous system involvement by COVID-19 is already an established entity in the literature. The aim of this study was to evaluate in detail the acute and delayed neurological manifestations of COVID -19.
RESULTS: COVID-19 infection can cause various neurologic manifestations and imaging findings. The most common neuroradiological abnormality is cerebrovascular events, which can also occur as a sequela of the infection. This study found a lower mean age of presentation in patients with cerebrovascular events, but no significant association was found between acute neurologic manifestations and demographic factors (like age, sex) or concomitant diseases. The severity of COVID-19 infection, as measured by the CT severity index (1), did not significantly impact neuroimaging findings, suggesting that they can occur even in patients with milder pulmonary symptoms.
CONCLUSION: Understanding neuroimaging patterns in COVID-19 is crucial for patient care and preventive measures. This study offers a comprehensive insight into the topic.
JSS Academy of Higher Education & Research
Severe acute respiratory syndrome coronavirus, COVID-19, cerebrovascular accidents.
M A, Patil V.
NEUROIMAGING MANIFESTATATIONS IN COVID-19 AND ITS SEQUELAE.
Digital Journal of Clinical Medicine.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Diseases Commons, Health Information Technology Commons, Medical Education Commons, Medical Sciences Commons, Medical Specialties Commons, Mental and Social Health Commons, Psychiatry and Psychology Commons, Public Health Education and Promotion Commons